American Century Companies’s Arcturus Therapeutics ARCT Stock Holding History

American Century Companies's ARCT Position: Q1 2026 in Review

American Century Companies reduced its Arcturus Therapeutics (ARCT) stake by 0.71% in Q1 2026, selling an estimated $3.45K and leaving 66,012 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

American Century Companies first reported a position in ARCT in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.83M in Q1 2024. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

• American Century Companies held 66,012 shares of Arcturus Therapeutics worth $510K as of Q1 2026.
• American Century Companies sold 473 Arcturus Therapeutics shares in Q1 2026, an estimated $3.45K.
• Arcturus Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2508 holding.
• American Century Companies first reported a position in Arcturus Therapeutics in Q2 2023 and has held it in 12 quarters since.
• American Century Companies's Arcturus Therapeutics position peaked at $7.83M in Q1 2024.
• 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.